Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow E-Letters: Submit a response to the article
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (5)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Fassoulaki, A.
Right arrow Articles by Sarantopoulos, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fassoulaki, A.
Right arrow Articles by Sarantopoulos, C.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

British Journal of Anaesthesia, Vol 81, Issue 3 358-360, Copyright © 1998 by The Board of Management and Trustees of the British Journal of Anaesthesia

CLINICAL INVESTIGATIONS

Effect of nimodipine on regression of spinal analgesia

A. Fassoulaki, M. Zotou and C. Sarantopoulos
Department of Anaesthesia, St Savas Hospital, 171 Alexandras Ave, 11522 Athens, Greece

We have investigated the effect of infusion of nimodipine on the spread of spinal anaesthesia in 50 patients undergoing transurethral procedures. Patients were allocated randomly to receive during operation continuous infusion of nimodipine 10 ml h-1 (group N, n = 25) or normal saline (group C, n = 25) in a double-blind manner. All patients received hyperbaric lidocaine 100 mg (5% in 8% dextrose) intrathecally and were then placed in the lithotomy position. Twenty minutes after intrathecal injection the level of spinal anaesthesia was tested with a pressure palpator and a baseline was established. Assessments were repeated 5, 10 and 15 min thereafter. Five minutes after establishing baseline, mean regression of sensory analgesia did not differ between groups. Analgesia had regressed by 1.3 (SD 1.4) and 1.0 (1.9) cm, respectively. After 10 min, sensory block in group N regressed by 1.7 (1.7) cm and in group C by 1.5 (1.6) cm. After 15 min these values were 1.1 (1.7) cm and 2.2 (1.9) cm, respectively (P < 0.035). Similar results were found after normalizing the changes by dividing the change by patient height.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Anesth. Analg.Home page
A. Paraskeva, V. Chatziara, I. Siafaka, M. Zotou, and A. Fassoulaki
Ropivacaine Spinal Anesthesia Is Not Antagonized by Ondansetron Pretreatment
Anesth. Analg., November 1, 2009; 109(5): 1684 - 1687.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
A. Fassoulaki, V. Chatziara, A. Melemeni, M. Zotou, and C. Sarantopoulos
Preoperative Gabapentin: The Effect on Ropivacaine Subarachnoid Block and Hemodynamics
Anesth. Analg., January 1, 2008; 106(1): 334 - 338.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
A. Fassoulaki, A. Melemeni, M. Zotou, and C. Sarantopoulos
Systemic Ondansetron Antagonizes the Sensory Block Produced by Intrathecal Lidocaine
Anesth. Analg., June 1, 2005; 100(6): 1817 - 1821.
[Abstract] [Full Text] [PDF]

Home page
 Br J AnaesthHome page
A. Fassoulaki, V. Gatzou, G. Petropoulos, and I. Siafaka
Spread of subarachnoid block, intraoperative local anaesthetic requirements and postoperative analgesic requirements in Caesarean section and total abdominal hysterectomy
Br. J. Anaesth., November 1, 2004; 93(5): 678 - 682.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.